FDA.reportPublic FDA data

lidocaine hydrochloride 0.5 MG Jet Injector [Zingo]

RxCUI
1011709
RxNorm name
lidocaine hydrochloride 0.5 MG Jet Injector [Zingo]
Display name
ZINGO (Injectable)
Full name
lidocaine hydrochloride 0.5 MG Jet Injector [Zingo]
Term type
SBD
Status
Active
Strength
0.5 mg
Dose form
Jet Injector
Route
Injectable
Updated
2026-08-01 06:51:22

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
lidocaine hydrochloride0.5 MG / 1 EACHlidocainelidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Jet Injector1649573

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
lidocaine6387

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRZingo 0.5 MG Jet InjectorNAMES
RxNorm Namelidocaine hydrochloride 0.5 MG Jet Injector [Zingo]NAMES
RxNorm SynonymZingo 0.5 MG Jet InjectorNAMES
TTYSBDATTRIBUTES
RxCUI1011709CODES
MMSL_CODEBD24372CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
70645012326rxnav_ndcsyes
28000010512rxnav_historical
29727010512rxnav_historical
53329020057rxnav_historical
61388000148rxnav_historical
61388012312rxnav_historical
61388012326rxnav_historical
61388012348rxnav_historical
70645012312rxnav_historical
70645012348rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
25368079-b2ac-4d31-e063-6394a90aa324Zingo 0.5 MG Jet InjectorSY820251110
25368079-b2ac-4d31-e063-6394a90aa324lidocaine hydrochloride 0.5 MG Jet Injector [Zingo]SBD820251110
25368079-b2ac-4d31-e063-6394a90aa324ZiNGO 0.5 MG Jet InjectorPSN820251110
ea5416d6-5988-413b-8682-6835b359eb78lidocaine hydrochloride 0.5 MG Jet Injector [Zingo]SBD2These highlights do not include all the information needed to use Zingo™ safely and effectively. See full prescribing information for Zingo™. Zingo™ (lidocaine hydrochloride monohydrate) powder intradermal injection system Initial U.S. Approval: 194820131101
ea5416d6-5988-413b-8682-6835b359eb78Zingo 0.5 MG Jet InjectorSY2These highlights do not include all the information needed to use Zingo™ safely and effectively. See full prescribing information for Zingo™. Zingo™ (lidocaine hydrochloride monohydrate) powder intradermal injection system Initial U.S. Approval: 194820131101
ea5416d6-5988-413b-8682-6835b359eb78ZiNGO 0.5 MG Jet InjectorPSN2These highlights do not include all the information needed to use Zingo™ safely and effectively. See full prescribing information for Zingo™. Zingo™ (lidocaine hydrochloride monohydrate) powder intradermal injection system Initial U.S. Approval: 194820131101
0fb7864f-be1c-4992-a996-556aef29981flidocaine hydrochloride 0.5 MG Jet Injector [Zingo]SBD2Zingo™ (lidocaine hydrochloride monohydrate powder intradermal injection system)20080625
0fb7864f-be1c-4992-a996-556aef29981fZiNGO 0.5 MG Jet InjectorPSN2Zingo™ (lidocaine hydrochloride monohydrate powder intradermal injection system)20080625
0fb7864f-be1c-4992-a996-556aef29981fZingo 0.5 MG Jet InjectorSY2Zingo™ (lidocaine hydrochloride monohydrate powder intradermal injection system)20080625

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
25368079-b2ac-4d31-e063-6394a90aa324Powder Pharmaceutical Incorporated20251110
25368079-b2ac-4d31-e063-6394a90aa324Powder Pharmaceutical Incorporated20251013
25368079-b2ac-4d31-e063-6394a90aa324Powder Pharmaceutical Incorporated20241005
ea5416d6-5988-413b-8682-6835b359eb78These highlights do not include all the information needed to use Zingo™ safely and effectively. See full prescribing information for Zingo™. Zingo™ (lidocaine hydrochloride monohydrate) powder intradermal injection system Initial U.S. Approval: 1948Powder Pharmaceuticals Inc.20131101
0FB7864F-BE1C-4992-A996-556AEF29981FZingo™ (lidocaine hydrochloride monohydrate powder intradermal injection system)Anesiva, Inc.20080625

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.5 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD24372
CODESRxCUI1011709
NAMESPrescribable SynonymZiNGO 0.5 MG Jet Injector
NAMESRXNAV_STRZingo 0.5 MG Jet Injector
NAMESRxNorm Namelidocaine hydrochloride 0.5 MG Jet Injector [Zingo]
NAMESRxNorm SynonymZingo 0.5 MG Jet Injector